The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Extraintestinal manifestations and complications in IBD
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Case Report and Literature Review
Spoden, J. E., Bumsted, R. M., & Warner, E. D. (1980) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348948008900320 · Cited by 1,094
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
Bernstein, C. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02319-x · Cited by 815
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases
Ramos-Casals, M., Brito-Zerón, P., Muñoz, S., Soria, N., Galiana, D., Bertolaccini, L., Cuadrado, M.-J., & Khamashta, M. A. (2007) · Medicine · doi:10.1097/md.0b013e3181441a68 · Cited by 733
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Orchard, T. R., Wordsworth, B. P., & Jewell, D. P. (1998) · Gut · doi:10.1136/gut.42.3.387 · Cited by 549
Rankin, G. B., Watts, H. D., Melnyk, C. S., & Kelley, M. L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90391-3 · Cited by 533
Siegel, C. A., Marden, S. M., Persing, S. M., Larson, R. J., & Sands, B. E. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.01.004 · Cited by 511
Bernstein, C. N., Blanchard, J. F., Leslie, W., Wajda, A., & Yu, B. N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-10-200011210-00012 · Cited by 474
Gasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., Gomollon, F., Hjortswang, H., Koutroubakis, I., Kulnigg, S., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20285 · Cited by 450
AGA technical review on osteoporosis in gastrointestinal diseases
Bernstein, C. N., Leslie, W. D., & Leboff, M. S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50106 · Cited by 412
Veloso, F. T., Carvalho, J., & Magro, F. (1996) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199607000-00009 · Cited by 373
Extraintestinal manifestations in inflammatory bowel disease
Danese, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i46.7227 · Cited by 373
Reduced bone density in patients with inflammatory bowel disease.
Bjarnason, I., Macpherson, A., Mackintosh, C., Buxton-Thomas, M., Forgacs, I., & Moniz, C. (1997) · Gut · doi:10.1136/gut.40.2.228 · Cited by 360
Extraintestinal manifestations and complications in inflammatory bowel diseases
Rothfuss, K., Stange, E. F., & Herrlinger, K. R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.12.4819 · Cited by 359
[Primary sclerosing cholangitis].
Molina Jurado, M., Ferrer, J., & Gómez, N. (1984) · PubMed · Cited by 335
Lakatos, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i10.2300 · Cited by 308
Osteoporosis in patients with inflammatory bowel disease.
Compston, J. E., Judd, D., Crawley, E. O., Evans, W. D., Evans, C., Church, H. A., Reid, E. M., & Rhodes, J. (1987) · Gut · doi:10.1136/gut.28.4.410 · Cited by 305
The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
Mielants, H., VEYS, E. M., De Vos, M., Cuvelier, C. A., Goemaere, S., Clercq, L. D., Schatteman, L., & Elewaut, D. S. (1995) · PubMed · Cited by 295
Genetic markers may predict disease behavior in patients with ulcerative colitis
Roussomoustakaki, M., Satsangi, J., Welsh, K., Louis, E., Fanning, G., Targan, S., Landers, C., & Jewell, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178675 · Cited by 275
Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.156 · Cited by 268
HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.
Brown, M. A., Pile, K. D., Kennedy, L. G., Calin, A., Darke, C., Bell, J., Wordsworth, B. P., & Cornélis, F. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.4.268 · Cited by 256
Grant, A. J., Lalor, P. F., Salmi, M., Jalkanen, S., & Adams, D. H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07374-9 · Cited by 255
Zochling, J., van der Heijde, D., Dougados, M., & Braun, J. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041129 · Cited by 247
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.
K, D. V., Mielants, H., Cuvelier, C. A., De Keyser, F., Veys, E. M., & De Vos, M. (2000) · PubMed · Cited by 247
Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer
Broomé, U., & Bergquist, A. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933561 · Cited by 244
Clinical patterns of familial inflammatory bowel disease.
Satsangi, J., Grootscholten, C., Holt, H., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.5.738 · Cited by 238
Tumor necrosis factor‐α antagonists and neuropathy
Stübgen, J. (2008) · Muscle & Nerve · doi:10.1002/mus.20924 · Cited by 236
Extraintestinal manifestations of inflammatory bowel disease
Su, C. G., Judge, T. A., & Lichtenstein, G. R. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00019-x · Cited by 234
Micronutrient deficiencies in inflammatory bowel disease: From A to zinc
Hwang, C., Ross, V., & Mahadevan, U. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22906 · Cited by 233
Sandborn, W. J., Stenson, W. F., Brynskov, J., Lorenz, R. G., Steidle, G. M., Robbins, J. L., Kent, J. D., & Bloom, B. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.002 · Cited by 231
Palm, Ø., Moum, B. A., Ongre, A. A., & Gran, J. T. (2002) · PubMed · Cited by 228
Van den Bosch, F., Kruithof, E., Vos, M. D., Keyser, F. D., & Mielants, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03239-6 · Cited by 220
Extraintestinal manifestations of inflammatory bowel disease
Ardizzone, S., Puttini, P. S., Cassinotti, A., & Porro, G. B. (2008) · Digestive and Liver Disease · doi:10.1016/s1590-8658(08)60534-4 · Cited by 212
Ocular Manifestations of Inflammatory Bowel Disease
Mintz, R., Feller, E. R., Bahr, R. L., & Shah, S. A. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00012 · Cited by 211
Parmar, M. S. (2004) · BMJ · doi:10.1136/bmj.328.7453.1420 · Cited by 208
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease
Navaneethan, U., & Shen, B. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21219 · Cited by 201
El Miedany, Y., Youssef, S., Ahmed, I., & El Gaafary, M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00384.x · Cited by 191
Das, K. M. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026629528233 · Cited by 190
Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis
Murphy, C. C., Ayliffe, W. H., Booth, A., Makanjuola, D., Andrews, P. A., & Jayne, D. (2004) · Ophthalmology · doi:10.1016/s0161-6420(03)00721-8 · Cited by 188
Joo, M., Abreu-e-Lima, P., Farraye, F., Smith, T., Swaroop, P., Gardner, L., Lauwers, G. Y., & Odze, R. D. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318196d018 · Cited by 184
Cutaneous manifestations of gastrointestinal disease
Shah, K. R., Boland, C. R., Patel, M., Thrash, B., & Menter, A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.10.037 · Cited by 176
Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin
Leitgeb, C., Pecherstorfer, M., Fritz, E., & Ludwig, H. (1994) · Cancer · doi:10.1002/1097-0142(19940515)73:10<2535::aid-cncr2820731014>3.0.co;2-5 · Cited by 167
Hepatosplenic T cell lymphoma in inflammatory bowel disease: Table 1
Shale, M., Kanfer, E., Panaccione, R., & Ghosh, S. (2008) · Gut · doi:10.1136/gut.2008.163279 · Cited by 159
Important cutaneous manifestations of inflammatory bowel disease
Trost, L. B., & McDonnell, J. K. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.031633 · Cited by 158
BRINK, M., SLORS, J., KEULEMANS, Y., MOK, K., DEWAART, D., CAREY, M., GROEN, A., & TYTGAT, G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70507-x · Cited by 158
Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease
Mahadevan, U., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05608.x · Cited by 155
The joint–gut axis in inflammatory bowel diseases
Brakenhoff, L., van der Heijde, D. M. F. M., Hommes, D. W., Huizinga, T. W. J., & Fidder, H. H. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.11.005 · Cited by 155
Renal and Urologic Complications of Inflammatory Bowel Disease
Pardi, D. S., Tremaine, W. J., Sandborn, W. J., & McCarthy, J. T. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.156_b.x · Cited by 154
Cutaneous manifestations of gastrointestinal disease
Thrash, B., Patel, M., Shah, K. R., Boland, C. R., & Menter, A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.10.036 · Cited by 150
Infections and inflammatory diseases as risk factors for venous thrombosis: A systematic review
Kluin‐Nelemans, H. C., Meijer, K., & Tichelaar, Y. I. G. V. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-09-0611 · Cited by 148
Low bone mineral density in patients with inflammatory bowel disease
Pigot, F., Roux, C., Chaussade, S., Hardelin, D., Pelleter, O., Montbrun, T. D. P., Listrat, V., Dougados, M., Couturier, D., & Amor, B. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01296010 · Cited by 148
Kefalakes, H., Stylianides, T. J., Amanakis, G., & Kolios, G. C. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0719-3 · Cited by 142
Generini, S., Giacomelli, R., Fedi, R., Fulminis, A., Pignone, A. M., Frieri, G., Rosso, A. D., Viscido, A., Galletti, B., Fazzi, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012450 · Cited by 142
Salmi, M., & Jalkanen, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4650 · Cited by 137
Primary Sclerosing Cholangitis
Talwalkar, J. A., & Lindor, K. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00009 · Cited by 137
Palm, Ø. (2001) · British journal of rheumatology · doi:10.1093/rheumatology/40.11.1256 · Cited by 128
Focal white-matter lesions in brain of patients with inflammatory bowel disease
Andus, T., Roth, M., Kullmann, F., Caesar, I., Gross, V., Feuerbach, S., Schölmerich, J., Geißler, A., & Held, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90013-6 · Cited by 126
Self-citationAA amyloidosis: basic knowledge, unmet needs and future treatments
Obici, L. P., & Merlini, G. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13580 · Cited by 124
Extraintestinal Manifestations of Inflammatory Bowel Disease
Jose, F. A., & Heyman, M. B. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318093f4b0 · Cited by 123
Variant Forms of Cholestatic Diseases Involving Small Bile Ducts in Adults
Kim, W. R., Ludwig, J., & Lindor, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01999.x · Cited by 122
Trikudanathan, G., Venkatesh, P. G. K., & Navaneethan, U. (2012) · Drugs · doi:10.2165/11638120-000000000-00000 · Cited by 120
(2003) · Gastroenterology · doi:10.1053/gast.2003.50107 · Cited by 111
Herfarth, H. H., Obermeier, F., Andus, T., Rogler, G., Nikolaus, S., Kuehbacher, T., & Schreiber, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06064.x · Cited by 110
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia
Bager, P., Befrits, R., Wikman, O., Lindgren, S. C., Moum, B. A., Hjortswang, H., & Dahlerup, J. F. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.533382 · Cited by 109
Renal manifestations and complications of inflammatory bowel disease
Oikonomou, K. A., Kapsoritakis, A. N., Eleftheriadis, T., Stefanidis, I., & Potamianos, S. P. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21468 · Cited by 108
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases
Oussalah, A., Guéant, J., & Peyrin‐Biroulet, L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04864.x · Cited by 104
Neurologic manifestations in inflammatory bowel diseases: Current knowledge and novel insights
Zois, C. D., Katsanos, K. H., Kosmidou, M. S., & Tsianos, E. V. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.10.005 · Cited by 103
Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease.
Steer, S. E., Jones, H., Hibbert, J., Kondeatis, E., Vaughan, R., Sanderson, J. D., & Gibson, T. (2003) · PubMed · Cited by 102
Therapy Insight: vascular complications in patients with inflammatory bowel disease
Κoutroubakis, I. E. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0190 · Cited by 97
Pancreatitis in Inflammatory Bowel Diseases
Pitchumoni, C. S., Rubin, A., & Das, K. M. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181cadbe1 · Cited by 90
Primary chronic interstitial nephritis in Crohn's disease
Izzedine, H., Simon, J., Piette, A., Lucsko, M., Baumelou, A., Charitanski, D., Kernaonet, E., Baglin, A., Deray, G., & Beaufils, H. (2002) · Gastroenterology · doi:10.1053/gast.2002.36613 · Cited by 89
Pulmonary manifestations of inflammatory bowel disease: Case presentations and review
Basseri, B., Enayati, P. J., Marchevsky, A. M., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.03.008 · Cited by 85
Peeters, H., Cruyssen, B. V., Laukens, D., Coucke, P. J., Marichal, D., Berghe, M. V. D., Cuvelier, C. A., Remaut, E., Mielants, H., Keyser, F. D., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.021774 · Cited by 83
Reinisch, W., Miehsler, W., Dejaco, C., Harrer, M., Waldhoer, T., Lichtenberger, C., & Vogelsang, H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01596.x · Cited by 82
Palm, Ø., Bernklev, T., Moum, B. A., & Gran, J. T. (2005) · PubMed · Cited by 79
Neurologic Complications in Patients with Inflammatory Bowel Disease
Singh, S., Kumar, N., Loftus, E. V., & Kane, S. V. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23011 · Cited by 78
Herrlinger, K. R., Noftz, M. K., Fellermann, K., Schmidt, K. J., Steinhoff, J., & Stange, E. F. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00940.x · Cited by 77
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
Fonder, M. A., Cummins, D. L., Ehst, B. D., Anhalt, G. J., & Meyerle, J. H. (2006) · PubMed · Cited by 71
Voegtlin, M., Vavricka, S. R., Schoepfer, A. M., Straumann, A., Voegtlin, J., Rogler, G., Ballabeni, P., Pittet, V. E. H., Buser, A. S., Fried, M., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.07.008 · Cited by 70
Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease
Lakatos, P. L., Lakatos, L., Kiss, L. S., Peyrin‐Biroulet, L., Schoepfer, A. M., & Vavricka, S. (2012) · Digestion · doi:10.1159/000341950 · Cited by 66
The transition of acute to chronic bowel inflammation in spondyloarthritis
Praet, L. V., Jacques, P., den Bosch, F. E. V., & Elewaut, D. S. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.42 · Cited by 64
Erythema Nodosum and Pyoderma Gangrenosum in 50 Patients with Crohn’s Disease
Freeman, H. J. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/323914 · Cited by 63
Ott, C., Liebold, A., Takses, A., Strauch, U., & Obermeier, F. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/595970 · Cited by 61
Self-citationEndothelial Ligands and Homing of Mucosal Leukocytes in Extraintestinal Manifestations of IBD
Salmi, M., & Jalkanen, S. (1998) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780040210 · Cited by 57
Progress in the genetics of ankylosing spondylitis
Brown, M. A. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr023 · Cited by 48
Drug-Induced Nephrotoxicity in Inflammatory Bowel Disease
Oikonomou, K. A., Kapsoritakis, A. N., Stefanidis, I., & Potamianos, S. P. (2011) · Nephron Clinical Practice · doi:10.1159/000326682 · Cited by 46
Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard, P. (2004) · PubMed · Cited by 39
Hepatobiliary disorders and complications of inflammatory bowel disease
Venkatesh, P. G. K., Navaneethan, U., & Shen, B. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00511.x · Cited by 37
ABU-HIJLEH, M. A., Evans, S. K., & Aswad, B. I. (2010) · Lung · doi:10.1007/s00408-010-9259-y · Cited by 34
Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis
Liang, J., Wu, S., Feng, B., Lei, S.-N., Luo, G., Wang, J., Li, K., Li, X., Xie, H., Zhang, D., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0441-7 · Cited by 17
What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Kent, A. J., Blackwell, V., & Travis, S. P. L. (2012) · Current Drug Delivery · doi:10.2174/156720112801323026 · Cited by 5
Cited by
Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., Kaser, A., Peyrin-Biroulet, L., & Danese, S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0156-2 · Cited by 1,023
Extraintestinal Manifestations of Inflammatory Bowel Disease
Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., & Rogler, G. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000392 · Cited by 909
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Crohn Disease: Epidemiology, Diagnosis, and Management
Feuerstein, J. D., & Cheifetz, A. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.010 · Cited by 548
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
Loftus, E. V., Panés, J., Lacerda, A. P., Peyrin-Biroulet, L., D’Haens, G., Panaccione, R., Reinisch, W., Louis, E., Chen, M., Nakase, H., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212728 · Cited by 483
Metadata
- Authors
- Ott, C., & Schölmerich, J.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2013-07-09
- Volume
- 10
- Issue
- 10
- Pages
- 585-595
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2064748145
- Cited by
- 351
- References
- 95
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.